GLP-1 Drugs and Breast Cancer: What the Latest Research Says About Risk and Benefits

Join Dr. Sara Nunnery, Director of Breast Cancer Research at Tennessee Oncology, on the “Breast Cancer Briefing” podcast. This series offers expert analysis of the latest breast cancer clinical trials and research news, providing a vital resource for anyone following the evolving landscape of breast medical oncology.

In part 2 of this conversation, filmed live onsite at the 43rd Annual Miami Breast Cancer Conference, Nunnery sat down with Dr. Neil M. Iyengar, an associate professor and co-director of Breast Medical Oncology in the Department of Hematology and Medical Oncology at the Emory University School of Medicine, as well as the director of Survivorship Services at the Winship Cancer Institute of Emory University in Atlanta, Georgia.

Their conversation highlighted the evolving integration of GLP-1 agonists into the breast cancer treatment armamentarium.